Biopharma Modalities VC Trends: Selective Bets as Investors Seek De-risked Opportunities
Biopharma modalities' venture capital (VC) investments are becoming more selective, favoring proven assets over high-risk...
The Ethics of AI: Balancing Innovation with Responsibility
An ever-evolving technology, artificial intelligence (AI) is revolutionizing industries across the globe. From healthcare to...
ESG Data Utilization: Future Trends
Sustainability today has become a strategic and operational imperative for organizations. Investment, sustainability, and risk...
The Rise of Private Credit: Why Investors Are Betting Big on this Asset Class
Private credit has solidified its role as a dominant investment strategy, second only to private equity (PE). In 2024 alone,...
Leveraging ESG Data in Investment Decision-making
In today’s shifting investment landscape, ESG is no longer an option. Sustainability factors have become significantly...
Private Market Fundraising Slump: Temporary Dip or Structural Reset?
The global private market fundraising landscape in 2024 saw a significant decline, with total capital raised dropping by 19.1%...
Big Tech and AI: Shaping the New World Order
The advent of artificial intelligence (AI), particularly generative AI, has ushered organizations into a new era of technological...
VC-Backed Companies Are Driving M&A as Big Tech Pulls Back
Venture-backed startups, traditionally acquired by big corporations, are increasingly buying each other. In 2024, over one-third...
AI’s Power Problem Could Be a Big Break for Natural Gas
AI’s rapid rise comes with an overlooked consequence—an energy crunch. As data centers drive unprecedented...